XML 20 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Note 3 - Income Taxes
12 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

NOTE 3  –  INCOME TAXES

 

Components of income tax expense are as follows for the years ended:

 

  

September 30,

  

September 30,

 
  

2021

  

2020

 

Current:

        

Federal

 $5,154,287  $1,966,491 

State

  439,944   175,201 

Current income tax expense

  5,594,231   2,141,692 

Deferred:

        

Federal

  (234,297)  (252,929)

State

  46,947   (26,879)

Deferred income tax expense

  (187,350)  (279,808)

Income tax expense

 $5,406,881  $1,861,884 

 

The following is a reconciliation of the federal statutory income tax rate to the effective tax rate as a percent of pre-tax income for the following years ended:

 

  

September 30,

  

September 30,

 
  

2021

  

2020

 

Federal statutory rate

  21.0%  21.0%

State income taxes

  2.2%  2.0%

Permanent differences:

        

Change in valuation allowance

  -   (0.5%)

Expiration and utilization of state NOL’s

  -   0.4%

Research and development credits

  (0.7%)  (2.5%)

Excess tax expense (benefits) from stock-based compensation

  (1.5%)  (0.1%)

Tax rate

  21.0%  20.3%

 

As of September 30, 2021 and 2020, the current income tax payable was approximately $933,000 and $845,000, respectively. Current income tax payable amounts are included in Accrued Expenses in the Company’s balance sheets.

 

As of September 30, 2021 and 2020, the Company had no U.S. federal net operating loss (“NOL”) carry-forwards. The state NOL carryforwards of $769,000 at September 30, 2020 were fully utilized during fiscal 2021 resulting in no state NOL carryforwards at September 30, 2021. In addition, as of September 30, 2021, the Company had Minnesota research and development tax credits of $300,033. As of September 30, 2020, the Company had Minnesota research and development and alternative minimum tax credits of $337,000 and $32,000, respectively. The Company has not recorded a valuation allowance on these research and development related deferred tax assets as the Company believes it is more likely than not they will be utilized before they begin to expire in fiscal year 2031.

 

Significant components of deferred income tax assets and liabilities are as follows at:

 

  

September 30,

  

September 30,

 
  

2021

  

2020

 

Deferred income tax assets (liabilities):

        

Intangibles

 $(91,924) $(86,319)

Property and equipment depreciation

  (379,572)  (419,896)

Net operating loss carry forwards and credits

  300,032   351,446 

Stock-based compensation

  230,553   169,730 

Inventories

  518,526   386,296 

Prepaid expenses

  (48,505)  (43,233)

Accrued expenses and reserves

  519,408   467,010 

Goodwill

  (683,051)  (646,916)

Gross deferred tax asset (liability)

  365,467   178,118 

Valuation allowance

  -   - 

Net deferred tax asset (liability)

 $365,467  $178,118 

 

Realization of NOL carryforwards and other deferred tax temporary differences are contingent upon future taxable earnings.  The Company’s deferred tax assets were reviewed for expected utilization by assessing the available positive and negative factors surrounding their recoverability. As of September 30, 2021 and 2020, no valuation allowance was deemed necessary as the Company determined it was more likely than not that the Company’s deferred tax assets will be realized.

 

The valuation allowance activity for the years ended September 30, 2021 and 2020 is as follows: 

 

Year Ended

 

Balance at Beginning of Year

  

Income Tax Benefit

  

Reversal for State NOL Expiration and Utilization

  

Balance at End of Year

 

September 30, 2021

 $-  $-  $-  $- 

September 30, 2020

 $47,014  $(5,235) $(41,779) $- 

 

The Company is required to recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit.  For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.  The Company applies the interpretation to all tax positions for which the statute of limitations remained open.  The Company had no liability for unrecognized tax benefits and did not recognize any interest or penalties during the years ended September 30, 2021 or 2020.

 

The Company is subject to income taxes in the U.S. federal jurisdiction, and various state jurisdictions.  Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply.  With few exceptions, the Company is no longer subject to U.S. federal, state and local income tax examinations by tax authorities for fiscal years ending prior to 2004.  We are generally subject to U.S. federal and state tax examinations for all tax years since 2004 due to our NOL carryforwards and the utilization of the carryforwards in years still open under statute.